Cargando…
Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives
The mechanistic target of rapamycin (mTOR), via its two distinct multiprotein complexes, mTORC1, and mTORC2, plays a central role in the regulation of cellular growth, metabolism, and migration. A dysregulation of the mTOR pathway has in turn been implicated in several pathological conditions includ...
Autores principales: | Ong, Pei Shi, Wang, Louis Z., Dai, Xiaoyun, Tseng, Sheng Hsuan, Loo, Shang Jun, Sethi, Gautam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079084/ https://www.ncbi.nlm.nih.gov/pubmed/27826244 http://dx.doi.org/10.3389/fphar.2016.00395 |
Ejemplares similares
-
Commentary: Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
por: Renna, Maurizio
Publicado: (2016) -
Role of anthraquinones in combating insulin resistance
por: Xia, Wanru, et al.
Publicado: (2023) -
Insulin-induced mTOR signaling and gluconeogenesis in renal proximal tubules: A mini-review of current evidence and therapeutic potential
por: Nakamura, Motonobu, et al.
Publicado: (2022) -
Kun-Dan Decoction Ameliorates Insulin Resistance by Activating AMPK/mTOR-Mediated Autophagy in High-Fat Diet-Fed Rats
por: Su, Zuqing, et al.
Publicado: (2021) -
Chaihu Guizhi Ganjiang Decoction Ameliorates Pancreatic Fibrosis via JNK/mTOR Signaling Pathway
por: Cui, Lihua, et al.
Publicado: (2021)